Skip to main content
KPC PHARMACEUTICALS, INC. logo

KPC PHARMACEUTICALS, INC. — Investor Relations & Filings

Ticker · 600422 ISIN · CNE0000015P8 LEI · 3003007ZALHXKUFMKN96 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 2,727 across all filing types
Latest filing 2016-03-30 Annual Report
Country CN China
Listing Shanghai Stock Exchange 600422

About KPC PHARMACEUTICALS, INC.

https://en.kpc.com.cn/

KPC Pharmaceuticals, Inc. specializes in the research, development, and manufacturing of pharmaceutical products, with a significant focus on natural and botanical medicines. The company is a global leader in the production of artemisinin-based anti-malarial treatments, including artemether and its derivatives. Its portfolio encompasses a wide range of therapeutic areas, notably cardiovascular and cerebrovascular health, where it utilizes Panax notoginseng saponins as a core component. KPC integrates traditional medicinal knowledge with modern pharmacological techniques to develop standardized botanical extracts and chemical drugs. The organization operates extensive production facilities and research centers dedicated to drug discovery and quality control. Its business activities extend to the distribution of healthcare products and the provision of medical services, aiming to provide comprehensive health solutions through innovation in natural medicine and biotechnology.

Recent filings

Filing Released Lang Actions
2015年年度报告摘要
Annual Report Classification · 100% confidence The document is titled as the 2015 annual report summary of Kunming Pharmaceutical Group Co., Ltd. It contains detailed financial data for the year 2015, including total assets, revenue, net profit, quarterly financial indicators, shareholder information, business overview, and management discussion and analysis. It also mentions the audit report with an unqualified opinion by an accounting firm. The length of the document (over 11,000 characters) and the presence of comprehensive financial statements and analysis confirm it is the full annual report, not just an announcement or summary. Therefore, the document fits the definition of an Annual Report (10-K). FY 2015
2016-03-30 Chinese
2016年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal announcement of the resolutions passed at the 2016 second extraordinary general meeting of shareholders of Kunming Pharmaceutical Group Co., Ltd. It details the meeting date, attendance, voting results on specific proposals, and legal witness statements. The content focuses on the voting outcomes and procedural compliance rather than presenting a full report or financial statements. The document length is short (1947 characters) and it serves as an official disclosure of voting results from a shareholders' meeting. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2016-03-29 Chinese
2016年第二次临时股东大会的法律意见
Regulatory Filings Classification · 95% confidence The document is a legal opinion issued by a law firm regarding the convening, attendance, and voting procedures of a specific shareholders' meeting (the 2016 second extraordinary general meeting) of Kunming Pharmaceutical Group Co., Ltd. It details the legality and validity of the meeting and resolutions passed. It does not contain financial statements, audit results, or management discussion of financial performance. It is not a report itself but a legal opinion related to a shareholders' meeting. This type of document is best classified under Regulatory Filings (RNS) as it is a compliance/legal opinion filing related to corporate governance and shareholder meetings but does not fit other categories like AGM Information or Proxy Solicitation which would be more about materials or voting requests. The document length is short and focused on legal opinion, not a report or announcement of a report publication.
2016-03-29 Chinese
2016年第二次临时股东大会会议资料
AGM Information Classification · 95% confidence The document is titled as materials for the "2016 Second Extraordinary General Meeting" of Kunming Pharmaceutical Group Co., Ltd. It contains detailed meeting agenda, voting procedures, and specific proposals to be voted on, such as providing credit guarantees and amending the company charter. The content is focused on the meeting materials for a shareholders' meeting rather than the announcement of voting results or the minutes of the meeting. The document length is about 5248 characters, which is sufficient to contain detailed meeting materials. This matches the definition of AGM Information (AGM-R), which includes presentations and materials shared during the Annual General Meeting or Extraordinary General Meeting. It is not a voting results declaration (DVA) because it does not report the results, nor is it a proxy solicitation (PSI) because it is not explicitly soliciting votes but providing meeting materials. Therefore, the best classification is AGM Information (AGM-R).
2016-03-11 Chinese
八届二次监事会决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of a resolution passed by the Supervisory Board (监事会) of Kunming Pharmaceutical Group Co., Ltd. It details the meeting date, voting results, and mentions that the proposal to amend the company's articles of association will be submitted to the shareholders' meeting for approval. The document is short (458 characters) and serves as an official notice of a board/committee decision rather than a full report or detailed financial disclosure. It does not contain financial statements, audit information, or detailed management discussion. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or decisions by company boards or senior management bodies.
2016-03-09 Chinese
公司章程（2016修订）
Governance Information Classification · 100% confidence The document is titled '昆药集团股份有限公司章程' which translates to 'Articles of Association of KPC Pharmaceuticals, Inc.' It contains detailed chapters on company organization, shareholder rights, board structure, management, financial accounting, and other governance-related topics. The content includes provisions on shareholder meetings, board of directors, management responsibilities, share issuance, capital changes, and other corporate governance matters. There is no indication that this is a financial report, earnings release, or a meeting presentation. Instead, it is a governance document outlining the internal rules and structure of the company. Therefore, the document fits the category of Governance Information (CGR). The document length (15,000 characters) and detailed content support this classification with high confidence.
2016-03-09 Chinese

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.